ALB and hepatocellular carcinoma: The proportions of patients with albumin-bilirubin (ALBI) grade 1, better performance status, HCC with a maximum diameter of 2 cm or less, earlier BCLC stage, and higher prescribed dose for PBT were significantly higher in the non-perihilar HCC group.